The Evaluation of the Effectiveness, Safety and Tolerability of Treatment, Using a PSMA-Lu177, in Patients With ACC- an Open, Non-commercial Clinical Trial

Conditions: Adenoid Cystic Carcinoma Interventions: Drug: Lutetium (177Lu) vipivotide tetraxetan Sponsors: Maria Sklodowska-Curie National Research Institute of Oncology Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials